3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
35
Rectal Neoplasms
24
Stomach Neoplasms
19
Triple Negative Breast Neoplasms
16
Colorectal Neoplasms
14
Neoplasm Metastasis
12
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Nasopharyngeal Carcinoma
7
Adenocarcinoma Of Esophagus
7
Neoplasms
6
Colonic Neoplasms
6
Biliary Tract Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Pathologic Complete Response
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Locally Advanced Rectal Cancer
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Interventions
Fulvestrant
4
ribociclib
2
palbociclib
2
Irinotecan
2
Gemcitabine
2
venetoclax
1
tivozanib
1
serabelisib
1
sapanisertib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
STX-478
1
Paclitaxel
1
Metformin
1
Lomustine
1
Letrozole
1
Imlunestrant
1
Doxorubicin
1
Cetuximab
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Capecitabine
×
90 days
×
Clear all
No trials found.